Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ananthakrishnan

Showing results (501-510 of 592) with videos related to

Pageof 60
Sort By:
Inflammatory Bowel Diseases|September 3, 2015
Identification of Nonresponse to Treatment Using Narrative Data in an Electronic Health Record Inflammatory Bowel Disease CohortAshwin N Ananthakrishnan, Andrew Cagan, Tianxi Cai, et al.
Inflammatory Bowel Diseases|March 3, 2016
Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative ColitisAshwin N Ananthakrishnan, Andrew Cagan, Tianxi Cai, et al.
International Journal of Colorectal Disease|January 6, 2019
Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosisGrace C Lee, Sarah E Deery, Hiroko Kunitake, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2019
Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre studyTomer Adar, David Faleck, Saranya Sasidharan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2020
Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or UstekinumabAnne Hu, Paulo Gustavo Kotze, Alice Burgevin, et al.
Journal of the American Medical Informatics Association : JAMIA|September 17, 2016
Surrogate-assisted feature extraction for high-throughput phenotypingSheng Yu, Abhishek Chakrabortty, Katherine P Liao, et al.
Gastroenterology|October 20, 2025
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn's Disease: 2025 AGA Evidence SynthesisSiddharth Singh, M Hassan Murad, Yuhong Yuan, et al.
Digestive Diseases and Sciences|September 13, 2014
Mode of childbirth and long-term outcomes in women with inflammatory bowel diseasesAshwin N Ananthakrishnan, Alice Cheng, Andrew Cagan, et al.
Inflammatory Bowel Diseases|August 5, 2015
Common Genetic Variants Influence Circulating Vitamin D Levels in Inflammatory Bowel DiseasesAshwin N Ananthakrishnan, Andrew Cagan, Tianxi Cai, et al.
Pharmacoeconomics - Open|June 9, 2023
Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) in Patients with Crohn's Disease and Ulcerative ColitisEdward V Loftus, Ashwin N Ananthakrishnan, Wan-Ju Lee, et al.
Pageof 60

Showing results (501-510 of 592) with videos related to

Sort By:
Pageof 60
Inflammatory Bowel Diseases|September 3, 2015
Identification of Nonresponse to Treatment Using Narrative Data in an Electronic Health Record Inflammatory Bowel Disease CohortAshwin N Ananthakrishnan, Andrew Cagan, Tianxi Cai, et al.
Inflammatory Bowel Diseases|March 3, 2016
Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative ColitisAshwin N Ananthakrishnan, Andrew Cagan, Tianxi Cai, et al.
International Journal of Colorectal Disease|January 6, 2019
Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosisGrace C Lee, Sarah E Deery, Hiroko Kunitake, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2019
Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre studyTomer Adar, David Faleck, Saranya Sasidharan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2020
Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or UstekinumabAnne Hu, Paulo Gustavo Kotze, Alice Burgevin, et al.
Journal of the American Medical Informatics Association : JAMIA|September 17, 2016
Surrogate-assisted feature extraction for high-throughput phenotypingSheng Yu, Abhishek Chakrabortty, Katherine P Liao, et al.
Gastroenterology|October 20, 2025
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn's Disease: 2025 AGA Evidence SynthesisSiddharth Singh, M Hassan Murad, Yuhong Yuan, et al.
Digestive Diseases and Sciences|September 13, 2014
Mode of childbirth and long-term outcomes in women with inflammatory bowel diseasesAshwin N Ananthakrishnan, Alice Cheng, Andrew Cagan, et al.
Inflammatory Bowel Diseases|August 5, 2015
Common Genetic Variants Influence Circulating Vitamin D Levels in Inflammatory Bowel DiseasesAshwin N Ananthakrishnan, Andrew Cagan, Tianxi Cai, et al.
Pharmacoeconomics - Open|June 9, 2023
Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) in Patients with Crohn's Disease and Ulcerative ColitisEdward V Loftus, Ashwin N Ananthakrishnan, Wan-Ju Lee, et al.
Pageof 60